Invesco Ltd. Zai Lab LTD Transaction History

Invesco Ltd.

$499 Billion
Q3 2024

A detailed history of Invesco Ltd. transactions in Zai Lab LTD stock. As of the latest transaction made, Invesco Ltd. holds 42,550 shares of ZLAB stock, worth $1.12 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

42,550

Previous 44,006 3.31%

Holding current value

$1.12 Million

Previous $762,000 34.78%

% of portfolio

0.0%

Previous 0.0%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$16.25 - $24.14 $23,660 - $35,147	-1,456 Reduced 3.31%	42,550 $1.03 Million
Q2 2024 Aug 13, 2024	SELL	$13.72 - $21.55 $18,343 - $28,812	-1,337 Reduced 2.95%	44,006 $762,000
Q1 2024 May 14, 2024	SELL	$15.95 - $26.8 $29.5 Million - $49.5 Million	-1,848,186 Reduced 97.61%	45,343 $726,000
Q4 2023 Feb 12, 2024	SELL	$22.97 - $30.58 $30.2 Million - $40.2 Million	-1,315,774 Reduced 41.0%	1,893,529 $51.8 Million
Q3 2023 Nov 13, 2023	SELL	$22.72 - $31.49 $9.16 Million - $12.7 Million	-403,158 Reduced 11.16%	3,209,303 $78 Million
Q2 2023 Aug 11, 2023	SELL	$25.3 - $39.67 $30.1 Million - $47.2 Million	-1,190,165 Reduced 24.78%	3,612,461 $100 Million
Q1 2023 May 12, 2023	SELL	$30.21 - $48.1 $104 Million - $165 Million	-3,428,410 Reduced 41.65%	4,802,626 $160 Million
Q4 2022 Feb 13, 2023	SELL	$22.28 - $38.71 $2.12 Million - $3.68 Million	-95,093 Reduced 1.14%	8,231,036 $253 Million
Q3 2022 Nov 14, 2022	BUY	$34.2 - $51.69 $1.7 Million - $2.57 Million	49,696 Added 0.6%	8,326,129 $285 Million
Q2 2022 Aug 15, 2022	BUY	$23.14 - $49.68 $423,809 - $909,889	18,315 Added 0.22%	8,276,433 $287 Million
Q1 2022 May 16, 2022	BUY	$27.77 - $64.4 $28 Million - $64.8 Million	1,006,575 Added 13.88%	8,258,118 $363 Million
Q4 2021 Feb 14, 2022	BUY	$54.9 - $105.21 $140 Million - $269 Million	2,552,103 Added 54.31%	7,251,543 $456 Million
Q3 2021 Nov 15, 2021	BUY	$105.0 - $178.37 $345 Million - $586 Million	3,285,522 Added 232.37%	4,699,440 $495 Million
Q2 2021 Aug 17, 2021	BUY	$125.11 - $180.0 $161 Million - $232 Million	1,286,327 Added 1008.16%	1,413,918 $250 Million
Q1 2021 May 17, 2021	SELL	$126.27 - $191.71 $2.19 Million - $3.32 Million	-17,311 Reduced 11.95%	127,591 $17 Million
Q4 2020 Feb 16, 2021	BUY	$81.94 - $135.34 $1.1 Million - $1.81 Million	13,365 Added 10.16%	144,902 $19.6 Million
Q3 2020 Nov 16, 2020	BUY	$73.3 - $89.48 $1.6 Million - $1.95 Million	21,760 Added 19.82%	131,537 $10.9 Million
Q2 2020 Aug 14, 2020	BUY	$48.82 - $82.53 $3.83 Million - $6.47 Million	78,408 Added 249.95%	109,777 $9.02 Million
Q1 2020 May 15, 2020	SELL	$39.1 - $62.9 $656,215 - $1.06 Million	-16,783 Reduced 34.85%	31,369 $1.62 Million
Q4 2019 Feb 14, 2020	BUY	$29.79 - $43.06 $19,601 - $28,333	658 Added 1.39%	48,152 $2 Million
Q3 2019 Nov 14, 2019	BUY	$30.47 - $37.65 $312,073 - $385,611	10,242 Added 27.49%	47,494 $1.54 Million
Q2 2019 Aug 14, 2019	SELL	$25.73 - $35.79 $37,771 - $52,539	-1,468 Reduced 3.79%	37,252 $1.3 Million
Q1 2019 May 15, 2019	BUY	$21.71 - $31.54 $3,234 - $4,699	149 Added 0.39%	38,720 $1.14 Million
Q4 2018 Feb 14, 2019	BUY	$14.95 - $24.72 $576,636 - $953,475	38,571 New	38,571 $896,000

Others Institutions Holding ZLAB

# of Institutions

121

Shares Held

46.7M

Call Options Held

223K

Put Options Held

588K

View Full List

About Zai Lab Ltd

Ticker ZLAB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 97,908,704
Market Cap $2.57B
Description
Zai Lab Limited develops and commercializes therapies to treat oncology, autoimmune disorders, infectious diseases, and neuroscience primarily in Mainland China and Hong Kong. The company's commercial products include Zejula, a once-daily small-molecule poly polymerase 1/2 inhibitor; Optune, a device that delivers tumor treating fields; NUZYRA f...

More about ZLAB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Invesco Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Invesco Ltd. with notifications on news.

Account